Abstract In 2020, the World Health Organization launched a major initiative to eliminate
cervical cancer globally. The initiative is built around the three key pillars of human …

Introduction: Locally advanced cervical cancer (LACC)(International Federation of
Gynecology and Obstetrics (FIGO) 2009/2018–stages IB2-IVA/IB3-IVA, respectively) is …

Background Standard treatment for locally advanced cervical cancer is chemoradiotherapy,
but many patients relapse and die of metastatic disease. We aimed to determine the effects …

Cervical cancer is one of the most common cancers in the world both in terms of incidence
and mortality, more so important in low-and middle-income countries. Surgery and …

Cervical cancer is one of the most common cancers in developing nations. It has had a
tremendous impact on the lifetime of millions of women over the last century and continues …

Globally, cervical cancer has the fourth highest cancer incidence and mortality in women.
Cervical cancer is unique because it has effective prevention, screening, and treatment …

Background Currently, the standard treatment for locally advanced cervical cancer is
concurrent chemoradiation (CCRT). Forty percent of patients present with disease …

We investigated whether the addition of adjuvant chemotherapy to chemoradiation improves
overall survival (OS) and progression-free survival (PFS) by conducting a systematic review …

Management of locally advanced cervix cancer underwent major change 2 decades back
when concurrent chemotherapy (CCRT)(with cisplatin alone or in combination) along with …

Primary surgical management is successful as the sole therapeutic modality in the majority
of women with early-stage cervical, vaginal and vulvar cancer, but the presence of certain …